Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Vivo Opportunity Cayman Fund, L.P.

10% Owner at InMed Pharmaceuticals Inc. (INM)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$4K
Total bought / sold$32K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jul 16SEC INMInMed Pharmaceuticals Inc. Buy 4,882729,277 held (+1%) $1.55 $8K -12.3%
Jul 16SEC INMInMed Pharmaceuticals Inc. Buy 49373,628 held (+1%) $1.55 $764 -12.3%
Jul 16SEC INMInMed Pharmaceuticals Inc. Buy 13,761743,038 held (+2%) $1.55 $21K -12.3%
Jul 16SEC INMInMed Pharmaceuticals Inc. Buy 1,38975,017 held (+2%) $1.55 $2K -12.3%
Jul 16SEC INMInMed Pharmaceuticals Inc. Buy 19743,057 held (+0%) $1.55 $29 -12.3%
Jul 16SEC INMInMed Pharmaceuticals Inc. Buy 275,019 held (+0%) $1.55 $3 -12.3%
  • Buy

    10% Owner Vivo Opportunity Cayman Fund, L.P. bought $8K of INM at $1.55 — first open-market purchase in our records.

  • Buy

    10% Owner Vivo Opportunity Cayman Fund, L.P. bought $21K of INM at $1.55 — largest purchase by this insider in our records.